Compounds > hoechst 34580
Page last updated: 2024-11-08

hoechst 34580

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hoechst 34580: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID448202
SCHEMBL ID4997099
SCHEMBL ID19490889
MeSH IDM0573635

Synonyms (26)

Synonym
DB04011
2'-(4-dimethylaminophenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-benzimidazole
BBZ ,
n,n-dimethyl-4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]aniline
hoechst 34580
HY-15560
CS-1303
23555-00-2
SCHEMBL4997099
DTXSID40332276
SCHEMBL19490889
n,n-dimethyl-4-[5-(4-methylpiperazin-1-yl)-1h,1'h-2,5'-bibenzimidazol-2'-yl]aniline
BCP20754
hoe 34580;hoechst-34580;hoechst34580;hoe34580;hoe-34580
E76861
n,n-dimethyl-4-(5-(4-methylpiperazin-1-yl)-1h,1'h-[2,5'-bibenzo[d]imidazol]-2'-yl)aniline
Q27094867
EX-A2895
hoechst 34580; hoe 34580
A924225
BS-51407
hoe 34580
hoe 34580hoe 34580
YAA55500
hoechst34580
AKOS040744082
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.90 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
hoe 33342
bisbenzimide ethoxide trihydrochloride: benzimidazole fluorescent dye		2.1310
ConditionIndicatedRelationship StrengthStudiesTrials
Parasitemia
The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)		02.2110
Plasmodium falciparum Malaria
[description not available]		02.2110
Malaria, Falciparum
Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.		02.2110
Acute Confusional Senile Dementia
[description not available]		02.1310
Alzheimer Disease
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)		02.1310